Insider Stock Trading History of Thompson John Craig


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Thompson John Craig since year 2005. The trader's CIK number is 1509643. At the time of this reporting, Thompson John Craig is the President & CEO of Anthera Pharmaceuticals Inc . (stock ticker symbol ANTH). See this page for all insider trading activities at Anthera Pharmaceuticals Inc .

Note that in the past THOMPSON JOHN CRAIG also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Thompson John Craig since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-20 ANTH Anthera Pharmaceuticals Inc Buy 8,550 1.32 11,286
2017-09-07 ANTH Anthera Pharmaceuticals Inc Option Ex 10,400 1.43 14,892
2015-09-08 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 14.45 144,500
2015-09-08 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 44.08 440,800
2015-08-05 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 14.45 144,500
2015-08-05 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 46.31 463,100
2015-07-06 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 14.45 144,500
2015-07-06 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 47.91 479,099
2015-06-15 TTPH Tetraphase Pharmaceuticals Inc Option Ex 10,000 14.45 144,500
2015-06-15 TTPH Tetraphase Pharmaceuticals Inc Sale 10,000 41.51 415,100
2015-06-08 TTPH Tetraphase Pharmaceuticals Inc Option Ex 22,499 14.45 325,110
2015-06-08 TTPH Tetraphase Pharmaceuticals Inc Sale 22,499 43.25 973,081
2015-05-15 TTPH Tetraphase Pharmaceuticals Inc Option Ex 30,000 14.45 433,500
2015-05-15 TTPH Tetraphase Pharmaceuticals Inc Sale 30,000 39.63 1,188,900
2011-08-22 TSRX Trius Therapeutics Inc Buy 133 6.48 861

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thompson John Craig (President & CEO of Anthera Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.